3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice
- PMID: 17306775
- DOI: 10.1016/j.biopsych.2006.11.005
3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice
Abstract
Background: The neurobiological mechanism underlying the reinforcing effects of 3,4-methylenedioxymethamphetamine (MDMA) remains unclear. The aim of the present study was to determine the contribution of the serotonin transporter (SERT) in MDMA self-administration behavior by using knockout (KO) mice deficient in SERT.
Methods: Knockout mice and wild-type (WT) littermates were trained to acquire intravenous self-administration of MDMA (0, .03, .06, .125, and .25 mg/kg/infusion) on a fixed ratio 1 (FR1) schedule of reinforcement. Additional groups of mice were trained to obtain food and water to rule out operant responding impairments. Microdialysis studies were performed to evaluate dopamine (DA) and serotonin (5-HT) extracellular levels in the nucleus accumbens (NAC) and prefrontal cortex (PFC), respectively, after acute MDMA (10 mg/kg).
Results: None of the MDMA doses tested maintained intravenous self-administration in KO animals, whereas WT mice acquired responding for MDMA. Acquisition of operant responding for food and water was delayed in KO mice, but no differences between genotypes were observed on the last day of training. MDMA increased DA extracellular levels to a similar extent in the NAC of WT and KO mice. Conversely, extracellular concentrations of 5-HT in the PFC were increased following MDMA only in WT mice.
Conclusions: These findings provide evidence for the specific involvement of SERT in MDMA reinforcing properties.
Similar articles
-
Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.Int J Neuropsychopharmacol. 2011 Aug;14(7):927-40. doi: 10.1017/S1461145710001215. Epub 2010 Oct 14. Int J Neuropsychopharmacol. 2011. PMID: 20942998
-
CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.Biol Psychiatry. 2008 Jun 1;63(11):1030-8. doi: 10.1016/j.biopsych.2007.09.003. Epub 2007 Oct 24. Biol Psychiatry. 2008. PMID: 17950256
-
Behavioural and neurochemical effects of combined MDMA and THC administration in mice.Psychopharmacology (Berl). 2007 Dec;195(2):255-64. doi: 10.1007/s00213-007-0879-8. Epub 2007 Aug 8. Psychopharmacology (Berl). 2007. PMID: 17684733
-
Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?Psychopharmacology (Berl). 2007 Jan;189(4):471-82. doi: 10.1007/s00213-006-0320-8. Epub 2006 Mar 23. Psychopharmacology (Berl). 2007. PMID: 16555062 Review.
-
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. doi: 10.1016/j.pbb.2007.10.003. Epub 2007 Oct 16. Pharmacol Biochem Behav. 2008. PMID: 18035407 Free PMC article. Review.
Cited by
-
The nucleus accumbens in reward and aversion processing: insights and implications.Front Behav Neurosci. 2024 Aug 9;18:1420028. doi: 10.3389/fnbeh.2024.1420028. eCollection 2024. Front Behav Neurosci. 2024. PMID: 39184934 Free PMC article. Review.
-
Drive and Instinct-How They Produce Relatedness and Addiction.Front Psychol. 2021 Jun 10;12:657944. doi: 10.3389/fpsyg.2021.657944. eCollection 2021. Front Psychol. 2021. PMID: 34177709 Free PMC article.
-
The Roles of Serotonin in Neuropsychiatric Disorders.Cell Mol Neurobiol. 2022 Aug;42(6):1671-1692. doi: 10.1007/s10571-021-01064-9. Epub 2021 Mar 2. Cell Mol Neurobiol. 2022. PMID: 33651238 Free PMC article. Review.
-
Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.Behav Brain Res. 2010 Mar 5;207(2):500-7. doi: 10.1016/j.bbr.2009.10.038. Epub 2009 Nov 3. Behav Brain Res. 2010. PMID: 19891989 Free PMC article.
-
5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.Int J Neuropsychopharmacol. 2014 Oct 31;18(3):pyu056. doi: 10.1093/ijnp/pyu056. Int J Neuropsychopharmacol. 2014. PMID: 25522398 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous